Rhabdomyosarcoma surgery: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 13: Line 13:
** Several biopsies are needed in case of narrow margins to identify residual disease.
** Several biopsies are needed in case of narrow margins to identify residual disease.
* If surgical excision could not be performed, 12 weeks chemotherapy is recommended.
* If surgical excision could not be performed, 12 weeks chemotherapy is recommended.
* Lymph nodes need to be assessed for further evaluation.


{| style="border: 0px; font-size: 90%; margin: 3px;" align=center
{| style="border: 0px; font-size: 90%; margin: 3px;" align="center"
|+ '''Treatment for rhabdomyosarcoma'''
|+ '''Treatment for rhabdomyosarcoma'''
! style="background: #4682B4; color:#FFF;" | Location
! style="background: #4682B4; color:#FFF;" | Location

Revision as of 16:52, 15 February 2019

Rhabdomyosarcoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Rhabdomyosarcoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Rhabdomyosarcoma surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Rhabdomyosarcoma surgery

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Rhabdomyosarcoma surgery

CDC on Rhabdomyosarcoma surgery

Rhabdomyosarcoma surgery in the news

Blogs on Rhabdomyosarcoma surgery

Directions to Hospitals Treating Rhabdomyosarcoma

Risk calculators and risk factors for Rhabdomyosarcoma surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Suveenkrishna Pothuru, M.B,B.S. [2]

Overview

Surgical resection of the rhabdomyosarcoma is often difficult or impossible because the tumor is usually embedded deep within the tissue, leaving it difficult to reach.

Surgery

  • Primary resection of tumor is one of the main prognostic factors in rhabdomyosarcoma.[1][2]
  • Based on tumor;s location, surgical resection may be different.
  • Findings of surgical resection is essential for risk stratification.
  • Surgical tumor resection must contain complete tumor removal with performing safe margin resection.
    • Although recommended safety margin is 2 cm, it is impossible to perform in children because of tissue limitation.[3]
    • Several biopsies are needed in case of narrow margins to identify residual disease.
  • If surgical excision could not be performed, 12 weeks chemotherapy is recommended.
  • Lymph nodes need to be assessed for further evaluation.
Treatment for rhabdomyosarcoma
Location Symptoms
Head and neck Wide local excision; chemotherapy +/- radiation therapy
Bone around the eye Biopsy; chemotherapy + radiation therapy
Extremities Wide local excision; resection of nearby lymph nodes; amputation for extensive tumors
Abdomen or pelvis Neoadjvant therapy with chemotherapy and radiotherapy; wide local excision
Paratesticular region Removal of testes and spermatic cord; ipsilateral retroperitoneal lymphnode resection

References

  1. Schalow EL, Broecker BH (2003). "Role of surgery in children with rhabdomyosarcoma". Med Pediatr Oncol. 41 (1): 1–6. doi:10.1002/mpo.10261. PMID 12764734.
  2. PDQ Pediatric Treatment Editorial Board. Childhood Rhabdomyosarcoma Treatment (PDQ®): Health Professional Version. 2019 Jan 29. In: PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK65802/
  3. Dasgupta R, Fuchs J, Rodeberg D (2016). "Rhabdomyosarcoma". Semin Pediatr Surg. 25 (5): 276–283. doi:10.1053/j.sempedsurg.2016.09.011. PMID 27955730.

Template:WH Template:WS